000 | 01643 a2200397 4500 | ||
---|---|---|---|
005 | 20250514232708.0 | ||
264 | 0 | _c20050922 | |
008 | 200509s 0 0 eng d | ||
022 | _a0934-9723 | ||
024 | 7 |
_a10.1007/s10096-005-1355-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChamorro, A J | |
245 | 0 | 0 |
_aReactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cJul 2005 |
||
300 |
_a492-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aDNA, Viral _xblood |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHepatitis B _xcomplications |
650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
650 | 0 | 4 |
_aHepatitis B Core Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLamivudine _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRecurrence |
700 | 1 | _aCasado, J L | |
700 | 1 | _aBellido, D | |
700 | 1 | _aMoreno, S | |
773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 24 _gno. 7 _gp. 492-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10096-005-1355-1 _zAvailable from publisher's website |
999 |
_c15648015 _d15648015 |